The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Koshurnikova E.P.

Academician Ye.A. Vagner Perm State Medical University

Mishlanov V.Ju.

Academician Ye.A. Vagner Perm State Medical University

Zolotovskaya E.A.

Academician Ye.A. Vagner Perm State Medical University

Clinical markers of inflammation and myocardial remodeling in patients with chronic obstructive pulmonary diseases and chronic heart failure

Authors:

Koshurnikova E.P., Mishlanov V.Ju., Zolotovskaya E.A.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2025;28(11): 72‑78

Read: 527 times


To cite this article:

Koshurnikova EP, Mishlanov VJu, Zolotovskaya EA. Clinical markers of inflammation and myocardial remodeling in patients with chronic obstructive pulmonary diseases and chronic heart failure. Russian Journal of Preventive Medicine. 2025;28(11):72‑78. (In Russ.)
https://doi.org/10.17116/profmed20252811172

Recommended articles:
Therapeutic pote­ntial of quercetin and its deri­vatives against COVID-19. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):44-50

References:

  1. Xronicheskaya obstruktivnaya bolezn` legkix. Klinicheskie rekomendacii. M., 2021. Accessed May 24, 2025. (In Russ.). https://spulmo.ru/upload/kr/HOBL_2021.pdf
  2. Avdeev SN, Leshchenko IV, Aisanov ZR, on behalf of the working group for the development and revision of Federal recommendations for COPD. New recommendations for COPD — a shift of paradigm. Terapevticheskii arkhiv. 2024;96(3):292-297. (In Russ.). https://doi.org/10.26442/00403660.2024.03.202646
  3. Shubin IV, Mishlanov VYu, Koshurnikova EP. Clinical electronic register of patients with chronic obstructive pulmonary disease: analysis of factors associated with mortality. Vestnik sovremennoi klinicheskoi meditsiny. 2021; 14(1):62-68. (In Russ.). https://doi.org/10.20969/VSKM.2021.14(1).62-68
  4. Nikitin AE, Chereshnev VA, Mishlanov VYu, et al. Features of changes in echocardiography parameters in patients with chronic obstructive pulmonary disease and arterial hypertension. Klinicheskaya meditsina. 2018; 96(12):1088-1093. (In Russ.).
  5. Abrosimov VN, Avdeev SN, Chuchalin AG. Respiratornaya medicina: rukovodstvo v 3 t. 2-e izd., pererab. i dop. T. 1. M.: Litterra. 2017. (In Russ.).
  6. Tuev AV, Mishlanov VJu. Xronicheskie bronxoobstruktivny`e zabolevaniya i serdechno-sosudistaya sistema. Perm`: Presstajm. 2008. (In Russ.).
  7. Global Initiative for Chronic Obstructive Lung Disease, 2024 Report. Accessed May 24, 2025. https://goldcopd.org/wp-content/uploads/2024/02/GOLD-2024_v1.2-11Jan24_WMV.pdf
  8. Oakes JM, Xu J, Morris TM, et al. Effects of Chronic Nicotine Inhalation on Systemic and Pulmonary Blood Pressure and Right Ventricular Remodeling in Mice. Hypertension. 2020;75:1305-1314. https://doi.org/10.1161/HYPERTENSIONAHA.119.14608
  9. Bin He, Binxia Shao, Cheng Cheng, et al. miR-21-Mediated Endothelial Senescence and Dysfunction Are Involved in Cigarette Smoke-Induced Pulmonary Hypertension through Activation of PI3K/AKT/mTOR Signaling. Toxics. 2024;12(6):396.  https://doi.org/10.3390/toxics12060396
  10. Mareev VYu, Fomin IV, Ageev FT, et al. Russian Heart Failure Society, Russian Society of Cardiology. Russian Scientific Medical Society of Internal Medicine Guidelines for Heart failure: chronic (CHF) and acute decompensated (ADHF). Diagnostika, profilaktika i lechenie. Kardiologija. 2018; 58(6S):8-158. (In Russ.). https://doi.org/10.18087/cardio.2475
  11. Mishlanov VYu, Koshurnikova EP, Zolotovskaya EA. Additional criteria for the differential diagnosis of exacerbation of severe obstructive pulmonary disease and acute decompensated chronic heart failure. Russian Journal of Preventive Medicine. 2024;27(11):102-107. (In Russ.). https://doi.org/10.17116/profmed202427111102
  12. Patent RF na izobretenie RU №2824421 C1/07.08.2024. Mishlanov VJu, Koshurnikova EP, Zolotovskaya EA. Sposob diagnostiki xronicheskoj obstruktivnoj bolezni legkix. Accessed June 30, 2025. (In Russ.). https://www.fips.ru/cdfi/fips.dll/ru?ty=29&docid=2824421
  13. Chuchalin AG, Aysanov ZR, Chikina SYu, et al. Federal guidelines of Russian Respiratory Society on spirometry. Pulmonologiya. 2014;(6):11-24. (In Russ.). https://doi.org/10.18093/0869-0189-2014-0-6-11-24
  14. Marwick TH, Gillebert TC, Aurigemma G, et al. Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). European Heart Journal — Cardiovascular Imaging. 2015;16:577-605.  https://doi.org/10.1093/ehjci/jev076
  15. Ushakova LJu, Vertinsky EA, Chizh SA. Assessment of diastolic function of the left ventricle of the heart. Medicinskie novosti. 2018;12:34-38. (In Russ.).
  16. Chakraborty RK, Burns B. Systemic Inflammatory Response Syndrome. Treasure Island (FL): StatPearls Publishing; 2025 Jan. Accessed June 30, 2025. https://www.ncbi.nlm.nih.gov/books/NBK547669/
  17. Khazova EV, Bulashova OV. The role of systemic inflammation in heart failure. Kazanskii meditsinskii zhurnal. 2021;102(4):510-517. (In Russ.). https://doi.org/10.17816/KMJ2021-510
  18. Tokmachev RE, Kravchenko AYa. Budnevskij AV. The role of inflammation in the pathogenesis of chronic heart failure. Terapevticheskii arkhiv. 2016; 9:106-110. (In Russ.). https://doi.org/10.17116/terarkh2016889106-110
  19. Adamo L, Rocha-Resende C, Prabhu SD, et al. Reappraising the role of inflammation in heart failure. Nature reviews. Cardiology. 2020;17:269-285.  https://doi.org/10.1038/s41569-019-0315-x
  20. Xu Y, Yamashiro T, Moriya H, et al. Hyperinflated lungs compress the heart during expiration in COPD patients: a new finding on dynamic-ventilation computed tomography. International Journal of Chronic Obstructive Pulmonary Disease. 2017;12:3123-3131. https://doi.org/10.2147/COPD.S145599
  21. Barr RG, Bluemke DA, Ahmed FS, et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. New England Journal of Medicine. 2010;362(3):217-227.  https://doi.org/10.1056/NEJMoa0808836
  22. Watz H, Waschki B, Meyer T, et al. Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. Chest. 2010; 138(1):32-38.  https://doi.org/10.1378/chest.09-2810

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.